Viracept is a pharmaceutical drug that belongs to the class of antiretroviral medications used in the treatment of human immunodeficiency virus (HIV) infection. This drug is primarily prescribed for individuals infected with HIV-1, the most common strain of the virus, either alone or in combination with other antiretroviral drugs.
Viracept contains the active ingredient nelfinavir mesylate, which acts as a protease inhibitor. Protease is an enzyme that plays a crucial role in the replication of HIV, allowing the virus to form new copies and spread within the body. By inhibiting the activity of this enzyme, Viracept helps to slow down the progression of the virus and reduce its viral load in the bloodstream.
The drug is available in the form of oral tablets and should be taken orally with meals or light snacks to enhance its absorption. Viracept is usually prescribed as part of a comprehensive antiretroviral regimen, including other drugs, to achieve maximum effectiveness. It is crucial to strictly adhere to the prescribed dosage and follow the healthcare provider's instructions regarding timing, administration, and potential drug interactions.
As with any medication, Viracept may cause certain side effects, including diarrhea, nausea, headache, skin rash, and elevated liver enzymes. It is important to immediately notify a healthcare professional if any severe side effects or allergic reactions occur.
Overall, Viracept is a protease inhibitor-based medication used as part of combination antiretroviral therapy to manage HIV infection by reducing viral replication and slowing down the progression of the disease.
